drugset / Trial / NCT05086393

Duloxetine RCT on Postop TKA Outcomes

NCT05086393

Phase 4 Completed 241 enrolled Rush University Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to determine if duloxetine is associated with differences in post-operative pain, patient-reported outcome measures, and opioid consumption in patients undergoing primary total knee arthroplasty compared to patients who do not receive the medication. If so, duloxetine has the potential to become widely incorporated into the multi-modal analgesic regimen given to patients following knee replacements.

Timeline

Start
2021-11-01
Primary completion
2025-06-01
Completion
2025-07-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 30 mg Oral

Indications